Sustainable Financing

The Sustainable Financing team provides tools, strategic analysis and evidence to support advocacy for the adequate funding of harm reduction.

We are the only non-governmental organisation tracking harm reduction funding trends globally - including support provided by international donors and domestic governments - and the impact these have on the global HIV and other health responses.   

We support advocacy for increased investment in harm reduction, including campaigning for the redirection of funding from ineffective drug law enforcement to harm reduction and work with national partners to gather evidence to inform budget advocacy.

See below for examples of our work:

.......................................................................................................................................

Briefing: The impact of COVID-19 on harm reduction in seven Asian countries

This briefing summarises evidence from civil society in seven Asian countries (Cambodia, India, Indonesia, Nepal, Thailand, the Philippines and Vietnam) and provides recommendations to donors and governments on protecting harm reduction in the COVID-19 era.

.......................................................................................................................................

Redirection: What we are calling for: DEFUND + REDIRECT + INVEST

.......................................................................................................................................

The Impact of a Multi-Country Advocacy Grant on Progress towards 90-90-90 for people who use drugs

This briefing compiles evidence of the impact of the multi-country grant Harm Reduction Advocacy in Asia (HRAsia), funded by the Global Fund’s Catalytic Investments between 2017- 2020. It also highlights a number of ways in which multi-country grants for harm reduction play a crucial role in augmenting the potential of country-led programming… Read more

.......................................................................................................................................

Costing Tools for Harm Reduction Advocates

.......................................................................................................................................

HRI Working Papers - Supporting Global Fund Country Proposals 

.......................................................................................................................................

Summing it up: Building evidence to inform advocacy for harm reduction funding in Asia Summing it up: Building evidence to inform advocacy for harm reduction funding in Asia

Harm Reduction International developed tools for assessing national harm reduction investment and spending on drug law enforcement. This report presents the research findings generated by these tools in seven Asian countries.

.......................................................................................................................................

Making the investment case: Cost-effectiveness evidence for harm reduction Making the investment case: Cost-effectiveness evidence for harm reduction

This briefing compiles geographically diverse evidence to enable advocates to make the case for the cost-effectiveness of harm reduction.

.......................................................................................................................................

PCB 2019 Joint Statement INPUD + HRI International Network of People who Use Drugs (INPUD) and Harm Reduction International (HRI) Joint Statement Agenda item 1.4, Report by the NGO representative 45th UNAIDS Programme Committee Board.

........................................................................................................................................

We’re not there just yet: A joint statement on harm reduction and the Global Fund Sixth Replenishment

History was made last week in Lyon, when governments, philanthropic donors and the private sector pledged US$14 billion for the Sixth Global Fund Replenishment, more than any other global health institution has ever raised.

........................................................................................................................................

HR19 logo CTAPeople before politics: HR19 call to action on harm reduction funding and Global Fund replenishment

View and add your organisation to this Harm Reduction International Conference 2019 (HR19) call to action around harm reduction funding and the Global Fund's replenishment in 2019.

........................................................................................................................................

Joint Catalytic BriefingJoint Briefing with Frontline AIDS on Global Fund Catalytic Investments for Harm Reduction

This briefing, developed in collaboration with Frontline AIDS, compiles evidence on the crucial nature of the Global Fund's catalytic investment funds for harm reduction.

........................................................................................................................................

Lost decade report 2018The lost decade: Neglect for harm reduction funding and the health crisis among people who use drugs

Our 2018 publication tracked harm reduction funding in low- and middle-income countries (LMICs), showing a falls in international donor funding over a decade. 

........................................................................................................................................

10 by 20 logo 10 by 20 campaign 

Harm reduction is an evidence-based and cost-effective approach. It aims to keep people who use drugs, their families and communities safe and healthy. Our 10 by 20 campaign provides tools to advocates to push for the redirection of funding from drug law enforcement to harm reduction. 

........................................................................................................................................

Harm reduction in Asia front coverGlobal Fund Harm Reduction Advocacy in Asia

Harm Reduction International’s (HRI) preliminary research into the harm reduction funding landscape in Asia finds that there is a paucity of funding for HIV prevention, treatment, and care programmes for people who use drugs. 

........................................................................................................................................

Harm reduction decade coverThe Case for a Harm Reduction Decade: Progress, potential and paradigm shifts  

HIV-related deaths and new HIV infections among people who inject drugs could be almost entirely eliminated by 2030 with just a tiny shift in global drug control spending. Find out more in our 2016 study.

........................................................................................................................................

EU report coverHarm Reduction Investment in the European Union: Current funding, challenges and successes

Europe is the birthplace of harm reduction, and the region where the successes of this approach in averting epidemics can be most plainly seen. However, austerity, international donor retreat and poor political support are severely limiting harm reduction responses in several countries in the EU. 

........................................................................................................................................

Funding Report coverThe funding crisis for harm reduction

Our 2014 research with the International Drug Policy Consortium (IDPC) and International HIV/AIDS Alliance showed that without significant changes in government and donor priorities, the global HIV epidemic will not be halted. 

........................................................................................................................................

3 Cent Report 2010Three cents a day is not enough: Resourcing HIV-related harm reduction on a global basis

Our 2010 report found that only $160 million was being invested annually in harm reduction, with only a fraction going to direct services for people who use drugs. 

........................................................................................................................................

Funding for harm reduction during COVID-19 must be safeguarded and innovative measures must be preserved PDF document

People who use drugs, especially people who smoke or inject drugs, face additional risks and vulnerabilities to COVID-19 infection compared to the general population. Maintaining services for this population and safeguarding funding for harm reduction is therefore crucial.   The 2020 Global State of Harm Reduction reports that harm reduction… Read more

Calling for a Global Fund Strategy that can end AIDS among people who use drugs by 2030 PDF document

As the largest donor for harm reduction in low and middle-income countries, the Global Fund is pivotal to efforts to end AIDS among people who use drugs by 2030. Harm Reduction International and the International Network of People who Use Drugs urge Global Fund Board members to put communities at the front and centre of the Global Fund 2023-2028… Read more

Arguments d’investissement: rapport coût-efficacité de la réduction des risques

À l’ère de la réduction des financements internationaux visant la riposte au VIH, à l’hépatite C (VHC) et la tuberculose (TB), et des priorités concurrentes pour les investissements domestiques en faveur des programmes de santé, il y a de plus en plus d’accent mis sur l’optimisation des ressources, l’allocation efficace des ressources et la… Read more

Catherine Cook - Sustainable Financing Lead

Catherine Cook

Olga Szubert - Senior Policy Analyst

Olga Szubert

Emily Rowe - Sustainable Financing Focal Point – Asia

Emily Rowe

© 2021 Harm Reduction International.

Charity number – 1117375 | Company number – 3223265

Powered by Phoenix Media Group